Skip to main content
Main analysis: Amal Holdings: Diversification Worked, but 2026 Still Depends on the Home-Care Tender and Cash Discipline
ByMarch 30, 2026~8 min read

Amal Holdings: How Much Does the National Insurance Tender Really Threaten the Core Engine

The new National Insurance tender does not look like an event that wipes out Amal’s core business overnight. It does look like a hard test for the tariff structure of the home-care segment, which still accounts for roughly 61% of group revenue just as wage pressure is already narrowing the margin buffer.

The Real Threat Is Not Whether Amal Stays in the Market, but On What Margin

The main article argued that Amal’s diversification has improved, but that home care still remains the core engine. This continuation isolates the most sensitive question inside that engine: does the new National Insurance home-care tender really threaten the company’s central earnings base, or is this just another layer of regulatory noise the market may overread?

The short answer is that the threat is real, but narrower and more precise than a dramatic headline suggests. This does not currently look like an event that threatens to erase Amal’s home-care activity or push it out of the market. It does look like a threat to the economics of each service hour, meaning the margin structure of the segment that produced ILS 1.342 billion of revenue, ILS 107 million of operating profit, and roughly 61% of group revenue in 2025. When that is still the company’s main engine, even a modest deterioration in unit economics can materially change the read on the whole group.

The reason is straightforward. Home care operates under the National Insurance long-term-care framework and on an hourly tariff basis. In December 2025 Amal served 32,143 patients through 37 branches nationwide. This is a large, entrenched, and nationally spread operation. Precisely because it is so embedded, the tender risk sits less in whether the business survives and more in the compensation structure that governs it.

Home care is still the core engine even after the group broadened

What Exactly in the New Tender Worries the Company

This point needs to be stated carefully. The new tender is not a price tender. Like the current framework, it is a list tender. In other words, all bidders that meet the threshold requirements and pass the quality bar can be included in the provider list for the branches in which they qualify, and each patient then chooses the provider that serves them. This is not a winner-takes-all structure, so the first-layer fear of an immediate revenue cliff should be treated with more discipline.

The timeline also softens the near-term risk. After the October 27, 2025 court ruling, which instructed the tender committee to revisit and revise parts of the tender, the existing engagement with current providers, including Amal, was extended on October 28, 2025 through December 31, 2026 or until the tender process and contracting with winners are completed, whichever comes first. So anyone looking for an immediate cliff is simply not reading the package correctly.

But this is exactly where the real threat starts. Amal states twice, both in the business description and in the notes, that the new tender includes material changes in the tariff and in the tariff structure. It also says some of the criteria are unreasonable, some are outside the company’s control, and some are inconsistent with the requirements and budgeting embedded in the previous tender. That is no longer a generic complaint about regulation. It is language aimed directly at the economics of the segment.

It also matters what management says, and what it does not say. On one hand, management believes the company meets the threshold conditions and the quality metrics that are within its control. On the other hand, it does not say the new tender remains economically neutral for the company. Quite the opposite: it explicitly says that if the flaws are not corrected and the tender remains as is, the result could be some damage to the home-care segment’s results.

QuestionWhat the filings actually sayAnalytical implication
Is this a price tenderNo. It is a list tender without price competitionThe first-layer risk is lower than a sudden loss of the whole market
Is there an immediate revenue cliffThe current engagement was extended through December 31, 2026 or until the tender is completedThere is no immediate edge-of-the-cliff event today
Does Amal fear it will fail the basic qualification testNo. The company believes it meets the threshold and the quality criteria within its controlThe concern does not look like a simple eligibility problem
So where is the problemThe company highlights material changes in the tariff and tariff structureThe risk is concentrated in hourly economics and profitability
Can the company already quantify the hitNo. It says the impact cannot yet be estimatedThe uncertainty stays open until a corrected final version exists

Where the Sensitivity Is Already Visible Today

The new tender is not yet in force, but the filings already show how sensitive the segment margin is. In 2025 home-care revenue rose from ILS 1.282 billion to ILS 1.342 billion, yet operating profit slipped from ILS 108 million to ILS 107 million, and the operating margin fell from 8.4% to 7.9%. That matters because it shows that even under the current framework, higher revenue almost did not translate into a stronger operating line.

Management’s explanation is very sharp: most of the revenue increase came from tariff updates linked to minimum-wage changes and from higher activity, but expenses rose by almost the same amount, mainly because of wages. In other words, most of the incremental tariff income was absorbed back into labor cost. Once that is true, a change in tariff structure is not a technical detail. It is the economic core of the story.

Home care: revenue rose while operating margin compressed

Q4 makes the same point even more clearly. According to the board explanation, fourth-quarter 2025 revenue rose by about ILS 10 million, but that increase was driven by roughly ILS 15 million of tariff updates and partly offset by about ILS 5 million of lower sold hours. At the same time, expenses rose because wages increased. In the presentation, reported Q4 operating profit fell to about ILS 19 million and the margin dropped to 5.7%. Excluding roughly ILS 4 million of one-time listing-related expenses, operating profit would have been about ILS 23 million and the margin 6.8%.

The key point is not that the segment collapsed. It did not. Even in a pressured quarter it remained profitable. But the numbers do show that three things are enough to narrow the buffer: higher wages, some softness in sold hours, and a compensation structure that leaves too little absorption room. So if the new tender changes the tariff architecture, it will hit the exact place the filings already identify as sensitive.

Home care by quarter: revenue versus operating margin

What Management Is Actually Signaling

The most interesting sentence in this entire discussion is not that the company fears damage, but how it describes the response path. Amal says that if the flaws are not corrected, it intends to make the required adjustments over time in employee wage payments in order to reduce the extent of the damage. That is an important formulation because it indirectly acknowledges that the new tender could break the current economic balance, but also suggests management does not see the impact as a single uncontrollable event. It sees it as a problem that may be managed over time.

That also explains why the company writes two things that may look contradictory at first glance. On one side, it says the scope of the impact cannot yet be estimated. On the other side, it says the impact is not expected to be material to revenue, assuming the company is included in the winners list. There is no real contradiction here. Revenue and margin are two different stories. A company can stay inside the winners list, preserve most of the activity volume, and still face a less favorable segment economic model.

Another important clue sits in how the company chooses to fight. It does not stop at clarification questions. It also ties itself to a legal route, including through the Israeli home-care providers association. When a company repeats the same argument in the business description, in a dedicated note, and in connection with legal action, it is signaling that the dispute is not cosmetic. It is a dispute over the operating terms of the core engine.

Bottom Line

The National Insurance tender really does threaten Amal’s core engine, but not in the simplistic sense of “the company will lose home care.” The current threat looks like a threat to the margin architecture of home care. That is less dramatic in a headline, and much more important in the economics of the business.

The reason is twofold. On one side, there is real protection here: a list tender, an extension through year-end 2026, and management’s view that the company meets the threshold criteria. On the other side, that same core segment already showed in 2025 how sensitive the link is between tariff, hours, and wages. When the segment still generates more than half of group revenue, it does not take a dramatic shock to change the quality of earnings for the whole group.

So the key test is not only whether Amal ends up among the winners, but on what final tender terms, and how quickly it can preserve hourly economics once those terms become operational. If the tariff structure is corrected in a way that reasonably covers labor cost, the threat may look limited in hindsight. If not, what currently reads as “some” damage could become a prolonged erosion in the engine that still carries the group.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction